Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, May 27, 2014, 112 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $347.00 to $12,590,905.04.

Highlighted Stocks Traded by Insiders:

Cepheid (CPHD) - FREE Research Report

Kocmond Warren C Jr, who is EVP, Global Operations at Cepheid, sold 1,300 shares at $42.38 on May 27, 2014. Following this transaction, the EVP, Global Operations owned 0 shares meaning that the stake was reduced by 100% with the 1,300-share transaction.

The shares most recently traded at $44.96, up $2.58, or 5.75% since the insider transaction. Historical insider transactions for Cepheid go as follows:

  • 4-Week # shares sold: 1,621
  • 12-Week # shares sold: 1,621
  • 24-Week # shares sold: 1,621

The average volume for Cepheid has been 690,200 shares per day over the past 30 days. Cepheid has a market cap of $3.0 billion and is part of the technology sector and electronics industry. Shares are down 6.95% year-to-date as of the close of trading on Tuesday.

Cepheid, a molecular diagnostics company, develops, manufactures, and markets integrated systems for testing in the clinical and non-clinical markets; and for application in legacy non-clinical market. Currently, there are 9 analysts who rate Cepheid a buy, 1 analyst rates it a sell, and 7 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CPHD - FREE

TheStreet Quant Ratings

rates Cepheid as a

hold

. The company's strengths can be seen in multiple areas, such as its increase in stock price during the past year, robust revenue growth and largely solid financial position with reasonable debt levels by most measures. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and weak operating cash flow. Get the full

Cepheid Ratings Report

from

TheStreet Quant Ratings

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Campbell Soup (CPB) - FREE Research Report

Britt Irene Chang, who is Senior Vice President at Campbell Soup, sold 9,906 shares at $44.02 on May 27, 2014. Following this transaction, the Senior Vice President owned 109,889 shares meaning that the stake was reduced by 8.27% with the 9,906-share transaction.

The shares most recently traded at $44.88, up $0.86, or 1.92% since the insider transaction. Historical insider transactions for Campbell Soup go as follows:

  • 4-Week # shares sold: 55,000
  • 12-Week # shares sold: 55,000
  • 24-Week # shares sold: 55,000

The average volume for Campbell Soup has been 1.2 million shares per day over the past 30 days. Campbell Soup has a market cap of $13.8 billion and is part of the consumer goods sector and food & beverage industry. Shares are up 1.8% year-to-date as of the close of trading on Tuesday.

Campbell Soup Company, together with its subsidiaries, manufactures and markets branded convenience food products. It operates through U.S. Simple Meals; Global Baking and Snacking; International Simple Meals and Beverages; U.S. Beverages; and Bolthouse and Foodservice segments. The stock currently has a dividend yield of 2.83%. The company has a P/E ratio of 19.4. Currently, there is 1 analyst who rates Campbell Soup a buy, 3 analysts rate it a sell, and 10 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CPB - FREE

TheStreet Quant Ratings

rates Campbell Soup as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, growth in earnings per share, expanding profit margins, increase in net income and notable return on equity. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full

Campbell Soup Ratings Report

from

TheStreet Quant Ratings

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Carnival (CCL) - FREE Research Report

Ma 1994 B Shares Lp, who is See remarks at Carnival, sold 1,974 shares at $40.03 on May 27, 2014. Following this transaction, the See remarks owned 97.9 million shares meaning that the stake was reduced by 0% with the 1,974-share transaction.

The shares most recently traded at $39.37, down $0.66, or 1.68% since the insider transaction. Historical insider transactions for Carnival go as follows:

  • 4-Week # shares sold: 304,954
  • 12-Week # shares sold: 697,983
  • 24-Week # shares bought: 40,000
  • 24-Week # shares sold: 2.8 million

The average volume for Carnival has been 3.4 million shares per day over the past 30 days. Carnival has a market cap of $23.7 billion and is part of the services sector and leisure industry. Shares are down 0.37% year-to-date as of the close of trading on Tuesday.

Carnival Corporation operates as a cruise company worldwide. It operates in two segments, North America; and Europe, Australia, & Asia. The stock currently has a dividend yield of 2.5%. The company has a P/E ratio of 30.3. Currently, there are 4 analysts who rate Carnival a buy, 1 analyst rates it a sell, and 10 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CCL - FREE

TheStreet Quant Ratings

rates Carnival as a

hold

. The company's strengths can be seen in multiple areas, such as its reasonable valuation levels, good cash flow from operations and solid stock price performance. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and poor profit margins. Get the full

Carnival Ratings Report

from

TheStreet Quant Ratings

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null